Hyperfine (HYPR) EBIT (QoQ) (2021 - 2026)
Hyperfine (HYPR) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Hyperfine | 90.54 Mn | 45.77 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04% |
| Mar 31, 2026 | -11.61% |
| Dec 31, 2025 | 14.04% |
| Sep 30, 2025 | 7.03% |
| Jun 30, 2025 | 11.99% |
| Mar 31, 2025 | -1.27% |
| Dec 31, 2024 | 1.81% |
| Sep 30, 2024 | -1.08% |
| Jun 30, 2024 | -1.84% |
| Mar 31, 2024 | 8.42% |
| Dec 31, 2023 | 1.11% |
| Sep 30, 2023 | -0.57% |
| Jun 30, 2023 | 10.30% |
| Mar 31, 2023 | 4.36% |
| Dec 31, 2022 | -2.61% |
| Sep 30, 2022 | 42.73% |
| Jun 30, 2022 | 2.44% |
| Mar 31, 2022 | 8.88% |
| Dec 31, 2021 | -59.16% |
| Sep 30, 2021 | -12.37% |